Biosimilars
Article
Pharmacy in Focus
See the future taking shape in pharmacy and how you can capitalize and prepare for 2024 and beyond.
Read MoreArticle
Boosting Biosimilars Competition and Savings
September 25, 2023
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Article
Key considerations to support a robust biosimilar marketplace
July 24, 2023
We are taking a thoughtful and comprehensive approach to assessing biosimilar options that considers several factors.
Newsroom
Express Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients
Read More
Article
Express Scripts To Begin Adding Inflammatory Conditions Biosimilars to Largest Formularies Next Year
December 05, 2022
Article
The Pharmacy Benefit Management Team: Helping Patients Access Affordable Prescription Drugs Safely and Efficiently
November 28, 2022
Pharmacy benefit managers (PBMs) like Express Scripts are uniquely positioned to help patients in numerous ways.